U.S., Feb. 18 -- An application to own the trademark for 'NEXVOUND' has been filed on Nov. 21, 2025.
Owner(s):
Eli Lilly and Company; Lilly Corporate Center, , INDIANA
Goods and/or Services:
For: Medical information services in the field of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, ...